Table 3:
Variables | Hazard ratio (95% CI) | P-value |
---|---|---|
Adjuvant chemotherapy within 3 months after surgery | 1.62 (1.16–2.28) | 0.005 |
Age (years) | 1.00 (0.99–1.01) | 0.851 |
Female (versus male) | 1.24 (0.99–1.54) | 0.058 |
Body mass index (kg/m²) | 1.03 (1.00–1.07) | 0.084 |
Pathological staging (versus stage I) | ||
Stage II or more | 1.05 (0.75–1.48) | 0.765 |
Operation time (h) | 1.12 (1.00–1.25) | 0.046 |
Operation type (versus pneumonectomy or lobectomy) | ||
Segmentectomy | 0.75 (0.48–1.15) | 0.183 |
Wedge resection | 1.08 (0.73–1.61) | 0.688 |
Intraoperative analgesia (versus none) | ||
Intercostal nerve blockade | 0.71 (0.52–0.96) | 0.027 |
Percutaneous bupivacaine injection | 1.14 (0.81–1.62) | 0.449 |
NRS at first postoperative outpatient visit | 1.42 (1.36–1.49) | <0.001 |
Postoperative radiotherapy | 0.99 (0.68–1.45) | 0.975 |
Year of surgery (versus 2007) | ||
2008 | 0.74 (0.31–1.76) | 0.496 |
2009 | 0.42 (0.17–1.02) | 0.054 |
2010 | 0.55 (0.25–1.20) | 0.132 |
2011 | 0.93 (0.47–1.84) | 0.825 |
2012 | 0.57 (0.28–1.16) | 0.118 |
2013 | 0.45 (0.22–0.91) | 0.027 |
2014 | 0.57 (0.28–1.12) | 0.103 |
2015 | 0.51 (0.25–1.01) | 0.052 |
2016 | 0.40 (0.20–0.81) | 0.011 |
CI: confidence interval; NRS, numeric rating scale.